Shopping Cart
- Remove All
- Your shopping cart is currently empty
Fosravuconazole L-lysine ethanolate (BMS-379224 L-lysine ethanolate) is a broad-spectrum antifungal agent approved in Japan for treating onychomycosis, a fungal nail infection. It is a prodrug converted into ravuconazole.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $32 | In Stock | |
5 mg | $46 | In Stock | |
10 mg | $73 | In Stock | |
25 mg | $143 | In Stock | |
50 mg | $227 | In Stock | |
100 mg | $373 | In Stock | |
200 mg | $527 | In Stock |
Description | Fosravuconazole L-lysine ethanolate (BMS-379224 L-lysine ethanolate) is a broad-spectrum antifungal agent approved in Japan for treating onychomycosis, a fungal nail infection. It is a prodrug converted into ravuconazole. |
In vitro | Fosravuconazole exhibits potent in vitro antifungal activity against a broad spectrum of fungal species, including Candida, Aspergillus, and Trichophyton species [1]. |
In vivo | Fosravuconazole (E-1224; 10-50 mg/kg; oral administration; daily; for 20 days) suppresses parasitemia and prevents death in mice infected with the T. cruzi Y strain[2]. |
Alias | E-1224 L-lysine ethanolate, BMS-379224 L-lysine ethanolate |
Molecular Weight | 739.7 |
Formula | C31H40F2N7O8PS |
Cas No. | 914361-45-8 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 48 mg/mL (64.89 mM) | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.